\-\ Texto\\:\\ \ \(0\)\
\-\ patient\\ is\\ a\\ healthy\\ appearing\\ white\\ male\\.\\ \\ laboratory\\ values\\ are\\ unremarkable\\.\ \(0\)\
\-\ patient\\ is\\ treated\\ with\\ bronchial\\ lavage\\ when\\ symptomatic\\ and\\ followed\\ with\\ chest\\ radiographs\\ to\\ assess\\ for\\ evolution\\.\ \(0\)\
\-\ frontal\\ and\\ lateral\\ chest\\ radiographs\\ demonstrate\\ alveolar\\ consolidation\\ and\\ ground\\ glass\\ opacities\\ in\\ a\\ bilaterally\\ symmetric\\ pattern\\ with\\ a\\ predominantly\\ perihilar\\ distribution\\.\\ \\ no\\ pleural\\ effusions\\ are\\ present\\ and\\ the\\ lung\\ volumes\\ are\\ normal\\.\\ \\ the\\ chest\\ ct\\ demonstrates\\ patchy\\ areas\\ of\\ alveolar\\ consolidation\\.\ \(0\)\
\-\ alveolar\\ proteinosis\ \(5\)\
\-\ pulmonary\\ alveolar\\ proteinosis\ \(1\)\
\-\ pulmonary\\ edema\ \(53\)\
\-\ diffuse\\ bronchioalveolar\\ carcinoma\ \(0\)\
\-\ diffuse\\ infection\\ \ \(0\)\
\-\ pulmonary\\ hemorrhage\ \(11\)\
\-\ hypersensitivity\\ pneumonitis\ \(9\)\
\-\ 43\\-year\\-old\\ male\\ with\\ dyspnea\\ and\\ nonproductive\\ cough\\.\ \(1\)\
\-\ pulmonary\\ alveolar\\ proteinosis\\ is\\ a\\ disease\\ characterized\\ by\\ the\\ accumulation\\ of\\ proteinaceous\\ material\\ within\\ the\\ alveolar\\ spaces\\.\\ \\ the\\ cause\\ is\\ unknown\\.\\ \\ it\\ typically\\ affects\\ men\\ between\\ the\\ ages\\ of\\ 30\\ and\\ 50\\,\\ such\\ as\\ this\\ patient\\.\\ \\ patients\\ typically\\ present\\ with\\ a\\ nonproductive\\ cough\\ and\\ dyspnea\\.\ \(0\)\
\-\ chest\\ radiographs\\ demonstrate\\ a\\ bilaterally\\ symmetric\\ and\\ predominantly\\ hilar\\ or\\ perihilar\\ distribution\\ of\\ alveolar\\ consolidation\\ and\\ ground\\ glass\\ opacities\\.\\ \\ on\\ high\\ resolution\\ chest\\ ct\\ the\\ finding\\ of\\ patchy\\ ground\\ glass\\ opacities\\ with\\ thickened\\ septal\\ walls\\ is\\ termed\\ the\\ \\‚\\Ä\\úcrazy\\ paving\\‚\\Ä\\ù\\ pattern\\.\ \(0\)\
\-\ treatment\\ for\\ pap\\ is\\ with\\ bronchial\\ lavage\\.\\ \\ one\\-third\\ of\\ patients\\ will\\ typically\\ improve\\,\\ one\\-third\\ will\\ stay\\ the\\ same\\,\\ and\\ one\\-third\\ with\\ get\\ worse\\.\\ \\ pap\\ may\\ be\\ complicated\\ by\\ infection\\ with\\ nocardia\\,\\ aspergillus\\,\\ mycobacterial\\ or\\ mucor\\ species\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ alveolar\\:\\ 0\\.15005724580182914\ \(0\)\
\-\ proteinosis\\:\\ 0\\.08490853212966382\ \(0\)\
\-\ one\\-third\\:\\ 0\\.07698489356551623\ \(0\)\
\-\ nonproductive\\:\\ 0\\.06825522053282818\ \(0\)\
\-\ glass\\:\\ 0\\.06232332873603287\ \(0\)\
\-\ ground\\:\\ 0\\.059302242350334294\ \(0\)\
\-\ opacities\\:\\ 0\\.05620348231861647\ \(0\)\
\-\ consolidation\\:\\ 0\\.05398637307747784\ \(0\)\
\-\ pap\\:\\ 0\\.0539296063123372\ \(0\)\
\-\ lavage\\:\\ 0\\.051903034406312935\ \(0\)\
\-\ perihilar\\:\\ 0\\.048905765969853\ \(0\)\
\-\ chest\\:\\ 0\\.042956491597847035\ \(0\)\
\-\ pulmonary\\:\\ 0\\.04195882874319434\ \(0\)\
\-\ bronchial\\:\\ 0\\.040716189163146024\ \(0\)\
\-\ patchy\\:\\ 0\\.03849925982663226\ \(0\)\
\-\ typically\\:\\ 0\\.03802217356520133\ \(0\)\
\-\ crazy\\:\\ 0\\.03412761026641409\ \(0\)\
\-\ paving\\:\\ 0\\.03412761026641409\ \(0\)\
\-\ mucor\\:\\ 0\\.03412761026641409\ \(0\)\
\-\ radiographs\\:\\ 0\\.03411265766221176\ \(0\)\
\-\ dyspnea\\:\\ 0\\.03399019999580532\ \(0\)\
\-\ predominantly\\:\\ 0\\.03364146276129479\ \(0\)\
\-\ symmetric\\:\\ 0\\.03279717259017182\ \(0\)\
\-\ bronchioalveolar\\:\\ 0\\.03242397535839659\ \(0\)\
\-\ distribution\\:\\ 0\\.0323168497847941\ \(0\)\
\-\ 43\\-year\\-old\\:\\ 0\\.030277649208119317\ \(0\)\
\-\ nocardia\\:\\ 0\\.030277649208119317\ \(0\)\
\-\ species\\:\\ 0\\.02780795733878268\ \(0\)\
\-\ cough\\:\\ 0\\.027514746880740102\ \(0\)\
\-\ pattern\\:\\ 0\\.02744909528631326\ \(0\)\
\-\ aspergillus\\:\\ 0\\.02659920913520377\ \(0\)\
\-\ proteinaceous\\:\\ 0\\.02566163118850541\ \(0\)\
\-\ mycobacterial\\:\\ 0\\.024895574227186277\ \(0\)\
\-\ evolution\\:\\ 0\\.02424788229513897\ \(0\)\
\-\ volumes\\:\\ 0\\.024052420044572195\ \(0\)\
\-\ termed\\:\\ 0\\.024052420044572195\ \(0\)\
\-\ hypersensitivity\\:\\ 0\\.023865647932930036\ \(0\)\
\-\ pneumonitis\\:\\ 0\\.023865647932930036\ \(0\)\
\-\ bilaterally\\:\\ 0\\.023585758306923558\ \(0\)\
\-\ stay\\:\\ 0\\.022749248076909\ \(0\)\
\-\ will\\:\\ 0\\.022466227045202875\ \(0\)\
\-\ get\\:\\ 0\\.021983191115589867\ \(0\)\
\-\ diffuse\\:\\ 0\\.02173955815441441\ \(0\)\
\-\ infection\\:\\ 0\\.02087408885775468\ \(0\)\
\-\ affects\\:\\ 0\\.020438129014222983\ \(0\)\
\-\ ages\\:\\ 0\\.020358094581573012\ \(0\)\
\-\ men\\:\\ 0\\.02027955620757237\ \(0\)\
\-\ septal\\:\\ 0\\.01956569470843204\ \(0\)\
\-\ accumulation\\:\\ 0\\.019129573726576397\ \(0\)\
\-\ improve\\:\\ 0\\.019129573726576397\ \(0\)\
\-\ complicated\\:\\ 0\\.01862811676173368\ \(0\)\
\-\ patients\\:\\ 0\\.018584660498874167\ \(0\)\
\-\ effusions\\:\\ 0\\.018324248435768867\ \(0\)\
\-\ walls\\:\\ 0\\.018324248435768867\ \(0\)\
\-\ hilar\\:\\ 0\\.01804088170973722\ \(0\)\
\-\ assess\\:\\ 0\\.01799545769249261\ \(0\)\
\-\ values\\:\\ 0\\.017950519502926445\ \(0\)\
\-\ characterized\\:\\ 0\\.017862059800414547\ \(0\)\
\-\ spaces\\:\\ 0\\.01769053881503532\ \(0\)\
\-\ demonstrate\\:\\ 0\\.016524807910361684\ \(0\)\
\-\ present\\:\\ 0\\.016218560957409082\ \(0\)\
\-\ healthy\\:\\ 0\\.01618770501557391\ \(0\)\
\-\ thickened\\:\\ 0\\.016100469757387235\ \(0\)\
\-\ material\\:\\ 0\\.016043303152110854\ \(0\)\
\-\ appearing\\:\\ 0\\.01595898566030073\ \(0\)\
\-\ worse\\:\\ 0\\.01590369959064732\ \(0\)\
\-\ resolution\\:\\ 0\\.015485797096821113\ \(0\)\
\-\ same\\:\\ 0\\.01479921680353784\ \(0\)\
\-\ are\\:\\ 0\\.014683284107515989\ \(0\)\
\-\ symptomatic\\:\\ 0\\.014264636238210974\ \(0\)\
\-\ is\\:\\ 0\\.014175397774404849\ \(0\)\
\-\ unknown\\:\\ 0\\.014012098742119776\ \(0\)\
\-\ pleural\\:\\ 0\\.013942647893585278\ \(0\)\
\-\ 30\\:\\ 0\\.013807098052332246\ \(0\)\
\-\ 50\\:\\ 0\\.013659655532116826\ \(0\)\
\-\ \\‚\\Ä\\ú\\:\\ 0\\.013409667721761175\ \(0\)\
\-\ \\‚\\Ä\\ù\\:\\ 0\\.01333450148331254\ \(0\)\
\-\ laboratory\\:\\ 0\\.013231477881739772\ \(0\)\
\-\ male\\:\\ 0\\.012984920486449354\ \(0\)\
\-\ cause\\:\\ 0\\.012148162296436832\ \(0\)\
\-\ areas\\:\\ 0\\.012081290635487674\ \(0\)\
\-\ followed\\:\\ 0\\.012037293577221728\ \(0\)\
\-\ by\\:\\ 0\\.011956898346595586\ \(0\)\
\-\ hemorrhage\\:\\ 0\\.011950657916706032\ \(0\)\
\-\ white\\:\\ 0\\.011908000893747973\ \(0\)\
\-\ unremarkable\\:\\ 0\\.01188683369194143\ \(0\)\
\-\ finding\\:\\ 0\\.011571686995960005\ \(0\)\
\-\ between\\:\\ 0\\.011380233345480016\ \(0\)\
\-\ frontal\\:\\ 0\\.01127853753984604\ \(0\)\
\-\ such\\:\\ 0\\.011224087352272488\ \(0\)\
\-\ patient\\:\\ 0\\.010797377280458672\ \(0\)\
\-\ treated\\:\\ 0\\.010747272420520416\ \(0\)\
\-\ lung\\:\\ 0\\.010399828236297252\ \(0\)\
\-\ when\\:\\ 0\\.010282904359731115\ \(0\)\
\-\ carcinoma\\:\\ 0\\.010176166680738934\ \(0\)\
\-\ edema\\:\\ 0\\.01015514071189618\ \(0\)\
\-\ ct\\:\\ 0\\.01004456851589952\ \(0\)\
\-\ a\\:\\ 0\\.009998314331561377\ \(0\)\
\-\ high\\:\\ 0\\.00982582378603704\ \(0\)\
\-\ or\\:\\ 0\\.008416157554316869\ \(0\)\
\-\ it\\:\\ 0\\.00807079153165133\ \(0\)\
\-\ may\\:\\ 0\\.007875329281084554\ \(0\)\
\-\ demonstrates\\:\\ 0\\.007842946225433554\ \(0\)\
\-\ lateral\\:\\ 0\\.00775910943539727\ \(0\)\
\-\ and\\:\\ 0\\.007563403602194053\ \(0\)\
\-\ treatment\\:\\ 0\\.007267298149583558\ \(0\)\
\-\ within\\:\\ 0\\.006849291631874292\ \(0\)\
\-\ for\\:\\ 0\\.006126959232291724\ \(0\)\
\-\ disease\\:\\ 0\\.0058686451311584205\ \(0\)\
\-\ \\,\\:\\ 0\\.005687186250363181\ \(0\)\
\-\ normal\\:\\ 0\\.005628623758819752\ \(0\)\
\-\ be\\:\\ 0\\.005536792955226593\ \(0\)\
\-\ as\\:\\ 0\\.005430997923924906\ \(0\)\
\-\ the\\:\\ 0\\.005227914127448034\ \(0\)\
\-\ with\\:\\ 0\\.0044245276672647375\ \(0\)\
\-\ this\\:\\ 0\\.0040383916525803904\ \(0\)\
\-\ no\\:\\ 0\\.003615311557579\ \(0\)\
\-\ on\\:\\ 0\\.003041558875484992\ \(0\)\
\-\ of\\:\\ 0\\.0029370706083526495\ \(0\)\
\-\ \\.\\:\\ 0\\.002386523435115716\ \(0\)\
\-\ to\\:\\ 0\\.0017944038169873371\ \(0\)\
\-\ in\\:\\ 0\\.0017705765972279618\ \(0\)\
